2.5. Metformin and FOXA1 Deletion Enhance Tamoxifen-Mediated Tumor Cell Growth Inhibition in Hormone-Receptor-Positive Breast Cancer (HR+ BC) Cells. The gene discussed is NR4A1; the disease is breast cancer.